Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for
antibacterial agent
antimicrobial susceptibility testing
disk diffusion
sulopenem
susceptibility
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
20 07 2023
20 07 2023
Historique:
medline:
21
7
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
ppublish
Résumé
Sulopenem disk masses of 2, 5, 10, and 20 μg were evaluated by susceptibility testing isolates by broth microdilution and disk diffusion. A 2-μg disk was chosen, and error-rate bounding analysis in accordance with Clinical and Laboratory Standards Institute (CLSI) guideline M23 was conducted using a proposed sulopenem susceptible/intermediate/resistant (S/I/R) interpretive criterion of ≤0.5/1/≥2 μg/mL. Among the evaluated
Identifiants
pubmed: 37358462
doi: 10.1128/jcm.00246-23
pmc: PMC10358168
doi:
Substances chimiques
Anti-Bacterial Agents
0
sulopenem
120788-07-0
Lactams
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0024623Déclaration de conflit d'intérêts
The authors declare a conflict of interest. S.I.A. and S.P. are Full-time employees and own stocks: Iterum Therapeutics.
Références
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29743302
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29848564
Antimicrob Agents Chemother. 2018 Dec 21;63(1):
pubmed: 30397056
PLoS One. 2019 Dec 10;14(12):e0220265
pubmed: 31821338